Tech Company Financing Transactions
ARTAN Bio Funding Round
ARTAN Bio secured a $1 million Seed financing round on 7/2/2026. Backers included private investors.
Transaction Overview
Company Name
Announced On
7/2/2026
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Seed
Investors
private investors (Lead Investor) (Michael Torres)
Proceeds Purpose
The company intends to use the funds to advance its proprietary mutation-specific platform, fund formal Investigational New Drug (IND)-enabling preclinical research, scale up raw material manufacturing, and prepare for initial first-in-human clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1101 4th Street. South 300
?St. Petersburg, FL 33701
USA
?St. Petersburg, FL 33701
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
ARTAN is a biotechnology company developing a novel approach to address genetic and age-related diseases caused by nonsense mutations. These mutations lead to premature protein translation stops, resulting in incomplete and nonfunctional proteins. Our pipeline involves an engineered suppressor system that specifically recognizes these codons and restores normal protein translation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anthony Schwartz
Chief Scientific Officer
Michael Torres
Browse more venture capital transactions:
Prev: 7/2/2026: DJ Insight venture capital transaction
Next: 7/2/2026: RenaissThera venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs